The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeng, G.
Right arrow Articles by Wang, R.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeng, G.
Right arrow Articles by Wang, R.-F.
The Journal of Immunology, 2000, 165: 1153-1159.
Copyright © 2000 by The American Association of Immunologists

Identification of CD4+ T Cell Epitopes from NY-ESO-1 Presented by HLA-DR Molecules

Gang Zeng, Christopher E. Touloukian1, Xiang Wang1, Nicholas P. Restifo, Steven A. Rosenberg and Rong-Fu Wang2

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892

In previous studies, the shared cancer-testis Ag, NY-ESO-1, was demonstrated to be recognized by both Abs and CD8+ T cells. Gene expression of NY-ESO-1 was detected in many tumor types, including melanoma, breast, and lung cancers, but was not found in normal tissues, with the exception of testis. In this study, we describe the identification of MHC class II-restricted T cell epitopes from NY-ESO-1. Candidate CD4+ T cell peptides were first identified using HLA-DR4 transgenic mice immunized with the NY-ESO-1 protein. NY-ESO-1-specific CD4+ T cells were then generated from PBMC of a patient with melanoma stimulated with the candidate peptides in vitro. These CD4+ T cells recognized NY-ESO-1 peptides or protein pulsed on HLA-DR4+ EBV B cells, and also recognized tumor cells expressing HLA-DR4 and NY-ESO-1. A 10-mer peptide (VLLKEFTVSG) was recognized by CD4+ T cells. These studies provide new opportunities for developing more effective vaccine strategies by using tumor-specific CD4+ T cells. This approach may be applicable to the identification of CD4+ T cell epitopes from many known tumor Ags recognized by CD8+ T cells.




This article has been cited by other articles:


Home page
 JCOHome page
P. Sabbatini and K. Odunsi
Immunologic Approaches to Ovarian Cancer Treatment
J. Clin. Oncol., July 10, 2007; 25(20): 2884 - 2893.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Atanackovic, J. Arfsten, Y. Cao, S. Gnjatic, F. Schnieders, K. Bartels, G. Schilling, C. Faltz, C. Wolschke, J. Dierlamm, et al.
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation
Blood, February 1, 2007; 109(3): 1103 - 1112.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Zeng, M. E. Aldridge, X. Tian, D. Seiler, X. Zhang, Y. Jin, J. Rao, W. Li, D. Chen, M. P. Langford, et al.
Dendritic Cell Surface Calreticulin Is a Receptor for NY-ESO-1: Direct Interactions between Tumor-Associated Antigen and the Innate Immune System
J. Immunol., September 15, 2006; 177(6): 3582 - 3589.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Hasegawa, Y. Noguchi, F. Koizumi, A. Uenaka, M. Tanaka, M. Shimono, H. Nakamura, H. Shiku, S. Gnjatic, R. Murphy, et al.
In vitro Stimulation of CD8 and CD4 T Cells by Dendritic Cells Loaded with a Complex of Cholesterol-Bearing Hydrophobized Pullulan and NY-ESO-1 Protein: Identification of a New HLA-DR15-Binding CD4 T-Cell Epitope
Clin. Cancer Res., March 15, 2006; 12(6): 1921 - 1927.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Lepage and R. Lapointe
Melanosomal Targeting Sequences from gp100 Are Essential for MHC Class II-Restricted Endogenous Epitope Presentation and Mobilization to Endosomal Compartments
Cancer Res., February 15, 2006; 66(4): 2423 - 2432.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. Neumann, C. Wagner, K.-D. Preuss, B. Kubuschok, C. Schormann, S. Stevanovic, and M. Pfreundschuh
Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cells
Blood, November 1, 2005; 106(9): 3105 - 3113.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Paschen, M. Song, W. Osen, X. D. Nguyen, J. Mueller-Berghaus, D. Fink, N. Daniel, M. Donzeau, W. Nagel, H. Kropshofer, et al.
Detection of Spontaneous CD4+ T-Cell Responses in Melanoma Patients against a Tyrosinase-Related Protein-2-Derived Epitope Identified in HLA-DRB1*0301 Transgenic Mice
Clin. Cancer Res., July 15, 2005; 11(14): 5241 - 5247.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Zhao, Z. Zheng, P. F. Robbins, H. T. Khong, S. A. Rosenberg, and R. A. Morgan
Primary Human Lymphocytes Transduced with NY-ESO-1 Antigen-Specific TCR Genes Recognize and Kill Diverse Human Tumor Cell Lines
J. Immunol., April 1, 2005; 174(7): 4415 - 4423.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Mandic, F. Castelli, B. Janjic, C. Almunia, P. Andrade, D. Gillet, V. Brusic, J. M. Kirkwood, B. Maillere, and H. M. Zarour
One NY-ESO-1-Derived Epitope That Promiscuously Binds to Multiple HLA-DR and HLA-DP4 Molecules and Stimulates Autologous CD4+ T Cells from Patients with NY-ESO-1-Expressing Melanoma
J. Immunol., February 1, 2005; 174(3): 1751 - 1759.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. A. Vaughan, S. Svobodova, D. MacGregor, S. Sturrock, A. A. Jungbluth, J. Browning, I. D. Davis, P. Parente, Y.-T. Chen, E. Stockert, et al.
Immunohistochemical and Molecular Analysis of Human Melanomas for Expression of the Human Cancer-Testis Antigens NY-ESO-1 and LAGE-1
Clin. Cancer Res., December 15, 2004; 10(24): 8396 - 8404.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
I. D. Davis, W. Chen, H. Jackson, P. Parente, M. Shackleton, W. Hopkins, Q. Chen, N. Dimopoulos, T. Luke, R. Murphy, et al.
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans
PNAS, July 20, 2004; 101(29): 10697 - 10702.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Ruiz, H. Kobayashi, J. J. Lasarte, J. Prieto, F. Borras-Cuesta, E. Celis, and P. Sarobe
Identification and Characterization of a T-Helper Peptide from Carcinoembryonic Antigen
Clin. Cancer Res., April 15, 2004; 10(8): 2860 - 2867.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Palmowski, L. Lopes, Y. Ikeda, M. Salio, V. Cerundolo, and M. K. Collins
Intravenous Injection of a Lentiviral Vector Encoding NY-ESO-1 Induces an Effective CTL Response
J. Immunol., February 1, 2004; 172(3): 1582 - 1587.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Mandic, C. Almunia, S. Vicel, D. Gillet, B. Janjic, K. Coval, B. Maillere, J. M. Kirkwood, and H. M. Zarour
The Alternative Open Reading Frame of LAGE-1 Gives Rise to Multiple Promiscuous HLA-DR-restricted Epitopes Recognized by T-helper 1-type Tumor-reactive CD4+ T Cells
Cancer Res., October 1, 2003; 63(19): 6506 - 6515.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Ayyoub, D. Rimoldi, P. Guillaume, P. Romero, J.-C. Cerottini, D. Valmori, and D. Speiser
Tumor-reactive, SSX-2-specific CD8+ T Cells Are Selectively Expanded during Immune Responses to Antigen-expressing Tumors in Melanoma Patients
Cancer Res., September 1, 2003; 63(17): 5601 - 5606.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Gnjatic, D. Atanackovic, E. Jager, M. Matsuo, A. Selvakumar, N. K. Altorki, R. G. Maki, B. Dupont, G. Ritter, Y.-T. Chen, et al.
Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses
PNAS, July 22, 2003; 100(15): 8862 - 8867.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. S. Voo, T. Fu, H. E. Heslop, M. K. Brenner, C. M. Rooney, and R.-F. Wang
Identification of HLA-DP3-restricted Peptides from EBNA1 Recognized by CD4+ T Cells
Cancer Res., December 15, 2002; 62(24): 7195 - 7199.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. F. Robbins, M. El-Gamil, Y. F. Li, G. Zeng, M. Dudley, and S. A. Rosenberg
Multiple HLA Class II-Restricted Melanocyte Differentiation Antigens Are Recognized by Tumor-Infiltrating Lymphocytes from a Patient with Melanoma
J. Immunol., November 15, 2002; 169(10): 6036 - 6047.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Kobayashi, R. Omiya, M. Ruiz, E. Huarte, P. Sarobe, J. J. Lasarte, M. Herraiz, B. Sangro, J. Prieto, F. Borras-Cuesta, et al.
Identification of an Antigenic Epitope for Helper T Lymphocytes from Carcinoembryonic Antigen
Clin. Cancer Res., October 1, 2002; 8(10): 3219 - 3225.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Zeng, Y. Li, M. El-Gamil, J. Sidney, A. Sette, R.-f. Wang, S. A. Rosenberg, and P. F. Robbins
Generation of NY-ESO-1-specific CD4+ and CD8+ T Cells by a Single Peptide with Dual MHC Class I and Class II Specificities: A New Strategy for Vaccine Design
Cancer Res., July 1, 2002; 62(13): 3630 - 3635.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
H. Y. Wang, J. Zhou, K. Zhu, A. I. Riker, F. M. Marincola, and R.-F. Wang
Identification of a Mutated Fibronectin As a Tumor Antigen Recognized by CD4+T Cells: Its Role in Extracellular Matrix Formation and Tumor Metastasis
J. Exp. Med., June 3, 2002; 195(11): 1397 - 1406.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. M. Zarour, B. Maillere, V. Brusic, K. Coval, E. Williams, S. Pouvelle-Moratille, F. Castelli, S. Land, J. Bennouna, T. Logan, et al.
NY-ESO-1 119-143 Is a Promiscuous Major Histocompatibility Complex Class II T-Helper Epitope Recognized by Th1- and Th2-Type Tumor-reactive CD4+ T Cells
Cancer Res., January 1, 2002; 62(1): 213 - 218.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Lapointe, R. E. Royal, M. E. Reeves, I. Altomare, P. F. Robbins, and P. Hwu
Retrovirally Transduced Human Dendritic Cells Can Generate T Cells Recognizing Multiple MHC Class I and Class II Epitopes from the Melanoma Antigen Glycoprotein 100
J. Immunol., October 15, 2001; 167(8): 4758 - 4764.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Kobayashi, J. Lu, and E. Celis
Identification of Helper T-Cell Epitopes That Encompass or Lie Proximal to Cytotoxic T-Cell Epitopes in the gp100 Melanoma Tumor Antigen
Cancer Res., October 1, 2001; 61(20): 7577 - 7584.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Meyer zum Buschenfelde, J. Metzger, C. Hermann, N. Nicklisch, C. Peschel, and H. Bernhard
The Generation of Both T Killer and Th Cell Clones Specific for the Tumor-Associated Antigen HER2 Using Retrovirally Transduced Dendritic Cells
J. Immunol., August 1, 2001; 167(3): 1712 - 1719.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Deffrennes, J. Vedrenne, M.-C. Stolzenberg, J. Piskurich, G. Barbieri, J. P. Ting, D. Charron, and C. Alcaide-Loridan
Constitutive Expression of MHC Class II Genes in Melanoma Cell Lines Results from the Transcription of Class II Transactivator Abnormally Initiated from Its B Cell-Specific Promoter
J. Immunol., July 1, 2001; 167(1): 98 - 106.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Matsutake and P. K. Srivastava
The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein
PNAS, March 27, 2001; 98(7): 3992 - 3997.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Zeng, X. Wang, P. F. Robbins, S. A. Rosenberg, and R.-F. Wang
CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production
PNAS, March 16, 2001; (2001) 61507398.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Zeng, X. Wang, P. F. Robbins, S. A. Rosenberg, and R.-F. Wang
CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production
PNAS, March 27, 2001; 98(7): 3964 - 3969.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.